The fatty acid amide hydrolase (FAAH) regulates the endocannabinoid system cleaving primarily the lipid messenger anandamide. FAAH has been well characterized over the years and, importantly, it represents a promising drug target to treat several diseases, including inflammatory-related diseases and cancer. But its enzymatic mechanism for lipid selection to specifically hydrolyze anandamide, rather than similar bioactive lipids, remains elusive. Here, we clarify this mechanism in FAAH, examining the role of the dynamic paddle, which is formed by the gating residues Phe432 and Trp531 at the boundary between two cavities that form the FAAH catalytic site (the “membrane-access” and the “acyl chain-binding” pockets). We integrate microsecond-long MD simulations of wild type and double mutant model systems (Phe432Ala and Trp531Ala) of FAAH, embedded in a realistic membrane/water environment, with mutagenesis and kinetic experiments. We comparatively analyze three fatty acid substrates with different hydrolysis rates (anandamide > oleamide > palmitoylethanolamide). Our findings identify FAAH’s mechanism to selectively accommodate anandamide into a multi-pocket binding site, and to properly orient the substrate in pre-reactive conformations for efficient hydrolysis that is interceded by the dynamic paddle. Our findings therefore endorse a structural framework for a lipid selection mechanism mediated by structural flexibility and gating residues between multiple binding cavities, as found in FAAH. Based on the available structural data, this exquisite catalytic strategy for substrate specificity seems to be shared by other lipid-degrading enzymes with similar enzymatic architecture. The mechanistic insights for lipid selection might assist de-novo enzyme design or drug discovery efforts.
We describe a new structural enzymatic framework to regulate substrate specificity in lipid-degrading enzymes such as fatty acid amide hydrolase (FAAH), a key enzyme for the endocannabinoid lipid signaling that hydrolyzes a variety of lipids, however with different catalytic rates. The identified novel mechanism and key features for lipid selection in FAAH are then analysed in the context of other relevant lipid-degrading enzymes. Through the integration of microsecond-long molecular dynamics simulations with mutagenesis and kinetic experiments, our study suggests that structural flexibility, gating residues and multiple cavities in one catalytic site are keys to lipid selection in the endocannabinoid system. Our results suggest that the structural framework proposed here could likely be a general enzymatic strategy of other lipid-degrading enzymes to select the preferred lipid substrate within a broad spectrum of biologically active lipids. This new, and likely general, structural framework for lipid selection in FAAH could therefore now encourage additional experimental verifications of the role of ligand and structural flexibility, as regulated by key gating residues at the boundaries of multiple cavities forming a single catalytic site, as observed in several other lipid-degrading enzymes.
Citation: Palermo G, Bauer I, Campomanes P, Cavalli A, Armirotti A, Girotto S, et al. (2015) Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding Pockets. PLoS Comput Biol 11(6): e1004231. doi:10.1371/journal.pcbi.1004231
Editor: Dennis R. Livesay, UNC Charlotte, UNITED STATES
Received: January 13, 2015; Accepted: March 9, 2015; Published: June 25, 2015
Copyright: © 2015 Palermo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: MDV thanks the Italian Association for Cancer Research (AIRC) for financial support through the "MFAG n. 14140" Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Fatty acid amide hydrolase (FAAH—Fig 1) [1–3] and monoacylglycerol lipase (MAGL) are two hydrolytic enzymes that mainly regulate the endocannabinoid system. These enzymes act on the endocannabinoid signaling mostly through hydrolysis of the endogenous substrates anandamide and 2-arachidonoylglycerol (2-AG), respectively.[5–7] Both FAAH and MAGL can also hydrolyze other lipids although less efficiently.[8–10] Regulation of the endocannabinoid system is a promising strategy for treating pain, cancer, and other inflammatory-related diseases, suggesting both FAAH and MAGL as effective drug targets.[11–18] It is therefore crucial to decipher the mechanisms for substrate selection and catalysis, which might help in the rational design of new therapeutics that act by modulating the endocannabinoid system. Building on our own and other relevant studies on FAAH catalysis and inhibition,[19–33] we provide here an elucidation of the main structural and kinetic features involved in substrate selection during FAAH catalysis.
The enzyme is a homodimer, which is shown in gray ribbons. The lipids of the membrane are represented in cyan lines with the phosphate atoms highlighted as spheres. A close view of the binding site is shown on the right. The substrate anandamide is shown in yellow sticks, while the catalytic triad (Ser241-Ser217-Lys142) and the oxyanion hole (Ser241-Gly239-Gly240-Ser241) residues are represented in cyan sticks. The so called “membrane access” (MA—red) and the “acyl chain binding” (AB—orange) channels, as well as the “cytosolic port” (CP—cyan) are depicted in molecular surface representation. The interface region between the MA and AB channels is indicated as transition region (T). The Asp403 and Arg486 residues of the MA channel, which favor the substrates entrance within FAAH active site, are also shown as sticks. Key residues—Phe432 (green) and Trp531 (magenta)—are shown in space-filling representation. For clarity, explicit water molecules included in the simulations are omitted. The chemical structure of the FAAH substrates here considered—anandamide, oleamide, and palmitoylethanolamide (PEA)—is also shown.
Over the last decade, a wealth of experimental data has been generated on the structural properties and catalytic activity of FAAH.[5,7] FAAH is a homodimeric enzyme that can accommodate its substrate into a complex architecture of the catalytic site, which is characterized by three binding channels (Fig 1). Substrates are thought to reach the catalytic site via a membrane access (MA) channel where two charged residues (Asp403 and Arg486) may favor the entrance of the polar head groups of fatty acid molecules. The catalytic action of FAAH occurs in the core of the binding site where an unusual catalytic triad (Ser241–Ser217–Lys142) performs the hydrolysis of the substrate, while an oxyanion hole (Ile238–Gly239–Gly240–Ser241) keeps the substrate properly oriented for hydrolysis. Tightly connected to the catalytic region, a cytosolic port (CP) allows the exit of the leaving group after substrate hydrolysis. A third acyl-chain binding (AB) cavity, adjacent to the MA channel, seems to contribute to the proper accommodation of the substrate during catalysis.[1,7]
The enzymatic activity of FAAH has been measured using different enzyme preparations and substrates,[9,10] showing that the enzyme displays a preferential hydrolytic activity for arachidonoyl substrates (20:4 (Δ5,8,11,14)), such as anandamide. Other substrates such as oleamide or palmitoylethanolamide, which contain a lower degree of unsaturation, are hydrolyzed at significantly slower and time-dependent rates (~50 to 100 times slower than anandamide after 5 minutes of incubation). However, the structural and kinetic properties that regulate the preference of FAAH for its main substrate anandamide are still largely unknown. Based on structural data of FAAH, Mileni et al. originally proposed that the MA/AB boundary residue Phe432, in cooperation with the flexible residue Trp531, could act as a dynamic paddle that directs and orients the substrate during catalysis. This mechanistic hypothesis was further corroborated by our recent computational study, which suggested that anandamide is not fully locked into the AB channel during catalysis, as previously supposed.[7,25] Rather, our study suggested that anandamide assumes hydrolysis-prone conformations by moving its flexible arachidonoyl chain between the MA and AB cavities interceded by the dynamic paddle residues that act as a gate between these two binding cavities.
To test this hypothesis and to elucidate the enzymatic strategy for substrate selectivity, we carried out long-timescale molecular dynamics (MD) simulations of FAAH embedded in a realistic membrane/water environment in complex with three substrates with different hydrolysis rates (anandamide > oleamide > palmitoylethanolamide) for both wild type and double mutant (Phe432Ala and Trp531Ala) systems. These unbiased microsecond MD simulations were accompanied by corresponding mutagenesis and kinetic experiments, which further validated the crucial role of Phe432 and Trp531 for substrate specificity. The integration of our theoretical and experimental results suggests indeed that lipid selection is attained through interplay of substrate and protein flexibility regulated by the dynamic paddle. In particular, the selective binding of specific lipid substrates seems to be regulated by the dynamic paddle residues that act as a gate between multiple binding pockets and that actively favor the formation of pre-reactive conformations for the preferred fatty acid substrate anandamide.
We considered six model systems, each based on the X-ray structure of rat FAAH in complex with the anandamide analogue methyl arachidonoyl fluorophosphonate (MAFP), solved at 2.8 Å resolution (PDB code: 1MT5). As in our previous computational studies of FAAH,[24,25] these systems include the trans-membrane residues (9-29) and the N terminus, which were built by homology modeling. Three of these systems are formed by the wild type (wt) FAAH protein in complex with anandamide, oleamide, and palmitoylethanolamide (PEA) and are labeled wtFAAH/anandamide, wtFAAH/oleamide, and wtFAAH/PEA, respectively. The dynamic paddle residues (Phe432 and Trp531) were both mutated into alanine, obtaining the three corresponding double mutant systems (mut) mutFAAH/anandamide, mutFAAH/oleamide, and mutFAAH/PEA.
The initial binding mode of anandamide within the FAAH active site was taken from our previous studies.[24,25] Oleamide and PEA were docked using the Autodock 4.2 package. The acyl chain of all three substrates was initially located in the MA channel, as suggested in refs.[1,7] Full details on the docking calculations are reported in the S1 Text.
The six FAAH/substrate systems were embedded into an explicit membrane environment formed by 480 1-palmitoyl-2-oleoyl-phosphatidylethanolamine (POPE) lipids. Phosphatidylethanolamine is the major phospholipid of Escherichia coli membranes, which was used as an expression system to produce purified proteins for the crystallization of the rat FAAH protein. Each protein/membrane complex was hydrated with TIP3P waters and 8 Cl- counterions were added to neutralize the total charge. The size of the final systems was approximately ~145 Å x ~95 Å x ~140 Å, with ~35,500 water molecules and ~480 lipids, resulting in a total number of ~200,000 atoms for each system.
Molecular dynamics simulations
The all-atom AMBER/parm99 force field was adopted for the FAAH protein. The anandamide, oleamide, and PEA lipids were treated with the General Amber Force Field (GAFF) and the atomic charges were derived via the RESP fitting procedure. Force field parameters for the lipid bilayer were taken from our previous studies on FAAH catalysis.[24,25] Force field parameters for the non-standard residues were carefully validated via electronic structure calculations, confirming the accuracy of the force field parameters used here. The LINCS algorithm was used to constrain covalent bonds involving hydrogens, allowing a time integration step of 2 fs. All the simulations were performed using GROMACS 4. Long range electrostatic interactions were calculated with the particle mesh Ewald method with a real space cutoff of 10 Å. Periodic boundary conditions in the three directions of the Cartesian space were applied. The systems were coupled to a Nosé-Hoover thermostat[42,43] at a reference temperature of 310 K, and to an isotropic Parrinello-Rahman barostat at a reference pressure of 1 bar both with a coupling time of 1 ps. The following simulation protocol was adopted: the systems were minimized using a steepest descent algorithm and then slowly heated up to 310 K in 1000 ps. This approach has been shown to be efficient for the equilibration phase of large biological systems (∼200,000 total atoms).[25,45,46] Under these conditions, POPE is a liquid–crystalline bilayer,[47,48] ensuring a realistic environment for the FAAH protein. Crucial membrane properties for the pre-equilibrated POPE membrane used here were carefully analyzed and have been published in our previous paper. The simulations were performed with deprotonated Lys142, as proposed for the catalytic mechanism of FAAH.[1,49] Standard protonation states were maintained for the other protein residues. Approximately ~500–550 ns of MD simulations were collected in the NPT ensemble under standard conditions, for each of the six systems, resulting in a total of ~3–3.5 μs of dynamics. Coordinates of the systems were collected every 10 ps, for a total of ~50,000 frames for each run. Statistics were collected for the equilibrated systems after ~150 ns.
Binding free energies (ΔGBind) for the three ligands in the wt and mut FAAH systems were estimated by the Molecular Mechanics/Poisson Boltzmann Surface Area (MM/PBSA)[50,51] approach implemented in the Amber 12 package. Full details are given in the S1 Text.
Conformational and statistical analyses (see below) were performed over the equilibrated trajectories (last ~350 ns of MD) for all six simulations systems (~35,000 frames for each system). In all cases, both monomers yielded highly similar averages indicating that the system was well equilibrated (see S1 Text and S2-S3 Tables in S2 Text). Statistics were thus accumulated over both monomers resulting in an aggregate total sampling time of ~700 ns per system (~70,000 frames were considered for each system, with a total of ~420,000 analyzed frames). Data for each separate monomer of all the studied systems are also reported in S1 Text, S8 and S9 Figs, and S2 and S3 Tables in S2 Text.
Analysis of molecular dynamics data
The root-mean-square-deviation (RMSD) after the equilibration time (~150 ns) was used as stability indicator, with respect to the crystal structure (S3–S6 Figs). The location of the substrates in either the MA or AB channel during the trajectories was identified by calculating the minimum distances d between the center of mass of the last three atoms of each substrates and the centers of mass of residues of the MA channel [(Asp403, Ile407, Arg486, Ile530)—d-MA], of the AB channel [(Tyr335, Glu373, Arg428, Phe527)—d-AB], and of the MA/AB transition region [(Phe381, Phe432, Trp531)—d-T], as in Palermo et al. In detail, the substrates were located in MA if d-MA < 6 Å and d-AB > 6 Å; and in AB if d-MA > 6 Å and d-AB < 6 Å. If both these conditions were false and if d-T < 5 Å, the substrate’s acyl chain was considered to be located in the T region. The cutoff distances were chosen considering that the distance connecting the center of masses of the MA and AB channels is ~16/17 Å. Within this distance, ~6 Å each are occupied by the MA and AB channels, respectively (for a total of ~12 Å). The remaining ~4/5 Å therefore are considered as MA/AB interface region. The g-mindist tool of the GROMACS 4 package for MD analysis was used (S8 and S9 Figs). Full details on the substrate location are reported in S1 Text.
Conformational changes of the unsaturated lipids anandamide and oleamide were classified using the Applegate and Glomset notation. Accordingly to the latter, unsaturated lipids assume different conformations that can be grouped in three major shapes: (i) “elongated”; (ii) “hooked”, and (iii) “curved”.[54,55] Due to the absence of double bonds in the palmitoyl chain of PEA, conformational changes were followed in this case by considering the change of the lipid length (end-to-end distance) with respect to the initial configuration. This allowed identification of “elongated”, “hooked”, and “curved” conformations too. Full details on the conformational analysis of the FAAH substrates considered in this study can be found in the S1 Text.
Conformational changes of the key Phe432 and Trp531 residues within the FAAH binding site were characterized by using the torsion angle φ along their Cα-Cβ axis, namely φF for Phe432 and φW for Trp531. The pre-organization of the FAAH active site to perform substrate hydrolysis was assessed via the definition of catalytically significant conformational states (for simplicity, here referred to as “pre-reactive states”) of the FAAH/substrate complex. These substrate conformations are those characterized by optimal distances and orientations of key structural parameters involved in the enzymatic reaction, as explained in detail in Palermo et al. The structural parameters used here (S1 Text and S7 Fig) were identified based on several computational and crystallographic studies,[1,22,27,31,32,34,56] including our recent quantum mechanics/molecular mechanics (QM/MM) study of anandamide hydrolysis in FAAH. It is important to mention that our definition of pre-reactive states only concerns the predisposition of the substrate to undergo hydrolysis, given the proper relative orientation of the substrate with respect to the catalytic residues in the binding pocket of FAAH. Finally, to analyze the role of the dynamic paddle in pre-reactive conformations, we report the trend of the φF and φW angles with respect to the location of the anandamide acyl chain in the MA, T, and AB regions, using polar coordinates.
Acetonitrile was purchased from Sigma Aldrich (Italy). High purity standard anandamide and PEA were purchased from Cayman Chemical (Ann Arbor, MI, USA).
The rat (r)FAAHΔTM (97-1722bp) cDNA was amplified by PCR from the cDNA clone 7370226 purchased from Open Biosystem (Thermo Scientific) using the following primer pair: forward 5’-GGGAATTCCATATGGGGCGCCAGAAGGCCC-3’; reverse 5’-ATAGTTTAGCGGCCGCTCAATGATGATGATGATGATGAGGGGTCATCAGCTG-3’ containing the NdeI and NotI restriction sites. A (6x)Histidine tag was introduced in the reverse primer sequence (bold). The amplified rFAAHΔTM was then cloned in pMALc5x vector in frame with the N-terminal MBP and finally introduced into Escherichia coli Rosetta gami 2 (DE3)-pLysS strain.
The F432A and W531A mutants were generated by site-directed mutagenesis using the QuickChange II Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA) and the construct MBP-rFAAH-6xHis pMALc5x as template. The following primers were designed to introduce the single point-mutations Phe432Ala in rFAAH: forward 5’-CCTCGGCTGGCAGCCGCTCTCAACAGTATGCGTC-3’ and reverse 5’-GACGCATACTGTTGAGAGCGGCTGCCAGCCGAGG-3’; Trp531Ala in rFAAh forward 5’-GGCTACTTTGGGATATCGCGGACATCATCCTGAAG-3’ and reverse 5’-CTTCAGGATGATGTCCGCGATATCCCCAAAGTAGCC-3’.
Protein expression and purification
Overexpression of the MBP-rFAAH-6xHis proteins was achieved in E. coli strain Rosetta gami 2 (DE3)pLysS (Novagen) by growing cells in LB medium at 37°C to an OD600 of 0.6, followed by induction with 0.25 mM isopropyl β-D-thiogalactopyranoside for 16 hours at 25°C. Cells were then harvested by centrifugation, resuspended in buffer [50 mM sodium phosphate pH 7.4, 0.2 M sodium chloride, 10 mM imidazole], and lysed by sonication. The lysate was incubated for 1h at 4°C with benzonase nuclease, 2 μM MgCl2 and 1% Triton-X100. After centrifugation at 14,000 rpm for 30 min, the supernatant was incubated for 2 hours with NiNTA Agarose (Qiagen GmbH, Hilden, Germany) and washed with buffer containing increasing concentrations of imidazole (20 mM, 50 mM). Elution was performed with buffer containing 0.25 M imidazole. The buffer of the eluted sample was exchanged to 20 mM phosphate pH 7.4, 200 mM NaCl, 0.07% chaps.
Enzyme kinetics experiments
Enzymes (wt and mutants) were dissolved in Tris-HCl 100 mM, pH 7.4 buffer and preincubated at 37°C for 10 minutes. Each substrate was then individually incubated at different concentrations (3.3, 6.25, 12.5, 25, 33, 50 μM) with the enzymes. The highest substrate concentration was 50 μM and 33 μM for anandamide and PEA, respectively, due to limited substrate solubility. The final enzyme concentration was kept at 10 nM. Reaction was stopped after 30 minutes at 37°C by addition of cold acetonitrile, assuming that a steady state was reached (Michaelis Menten condition). After mixing and centrifugation, an aliquot of the supernatant was used for UPLC-MS/MS analysis. Each experiment was run in triplicate. Enzyme velocity was calculated as pmoles of substrate consumed per minute per μg of enzyme and plotted versus the concentration. Origin Pro 8.6 (OriginLab Corporation) was used to fit the velocity/concentration profiles and to determine the Michaelis Menten kinetic parameters (Vmax and Km).
Enzymes (wt and mutants) were dissolved at 10 nM concentration in Tris-HCl 100 mM, pH 7.4 buffer and preincubated at 37°C for 10 minutes. The reaction was then started by adding the substrates (anandamide and PEA) simultaneously up to a final 10 μM concentration. Final enzyme to substrate molar ratio was then 1 to 500. At different time points (0, 5, 15 and 30 minutes) an aliquot of the mixture was taken and the reaction was stopped by adding 4 volumes of cold acetonitrile. After mixing and centrifugation, an aliquot of the supernatant was used for UPLC-MS/MS analysis. Each experiment was run in triplicate. The incubation with rat liver microsomes (Tebu-Bio, Le Perray-en-Yvelines, France) was also prepared to run additional competition experiments (final concentration 0.1 mg/ml in the buffer).
LC-MS analysis of anandamide and PEA
Anandamide and PEA levels were measured by LC-MS/MS on a Xevo-TQ triple quadrupole mass spectrometer coupled with a UPLC chromatographic system. Analytes were separated on a reversed phase BEH C18 column, using a linear gradient of acetonitrile in water. Column, UPLC, and MS were purchased from Waters Inc, (Milford USA). Quantification was performed monitoring the MRM transitions of the analytes. Analyte peak areas were compared with a standard calibration curve prepared in the 1 nM to 10 mM concentration range.
Here, we considered five model systems together with the one reported recently in Palermo et al. (see Methods section). Thus, the six model systems used for the comparative analysis are: wild type (wt) and mutated (mut) FAAH in complex with either anandamide, oleamide, or palmitoylethanolamide (PEA). The three mutFAAH systems are lacking the dynamic paddle residues (i.e. with both mutations Phe432Ala and Trp531Ala).
After equilibration (~150 ns for each system), FAAH is stable in all simulations, meaning that the backbone RMSD of the protein with respect to the initial crystallographic structure oscillates around 3 ± 0.1 Å for all six systems (see detailed data in SI). Interestingly, these extended simulations evidenced different conformations and locations of the three lipids within the FAAH active site, as induced by the presence/absence of the key Phe432/Trp531 dynamic paddle. In our analysis, these different substrate configurations are related to the propensity of FAAH to perform substrate hydrolysis, according to the definition of catalytically significant conformations (i.e. pre-reactive states of the FAAH/substrate complex—see the Methods section).
As discussed in detail in our previous study, when initially located in the MA channel, anandamide reversibly transfers its arachidonoyl chain to the adjacent AB channel (Fig 2), without ever showing the arachidonoyl chain fully locked into the AB cavity.
(A) Time evolution of the φ angle for Phe432 (φF—green) and Trp531 (φW—violet) in the wtFAAH/anandamide (first row), wtFAAH/oleamide (second row), and wtFAAH/PEA (third row) systems, shown for Monomer-A (first column) and Monomer-B (second column). Averages are shown in solid lines. Angles are expressed in degrees. The thick bars indicate the values of the φ angle for Phe432 (φF ~65°) and Trp531 (φW ~180°) in the X-ray structure (see Methods). The background colors indicate the location of the substrates acyl chain in the wtFAAH binding site. The background is in red for substrates located in the MA channel, in yellow when in AB, and in cyan at the MA/AB transition (T) region. (B) Selected snapshots from MD simulations showing the MA<–>AB transitions of the substrates are reported. The MA (red) and AB (orange) channels are shown in molecular surface, while FAAH substrates are shown in yellow sticks. Specific configurations of the Phe432 (green) and Trp531 (violet) that favor the location on the substrates in the MA, T, and AB regions are also shown (the φ angle is explicitly reported).
After the equilibration time, 69% of the total anandamide configurations are located in the T region (where T stands for Transition region, which is located between the MA and AB pockets, Fig 3), while the population of the MA and AB channels is statistically less important (24% and 7%, respectively). Interestingly, pre-reactive conformations (27% of the production run) are mostly sampled while the lipid acyl chain is located in the T region (72%) and fewer conformations are located in the MA (21%) and AB (7%) channels. The anandamide’s tail preferentially assumes “curved” conformations due to the van der Waals interactions between its Δ 8/ Δ 11/ Δ14 double bonds and the aromatic rings of Phe432 and Phe381 (Figs 3 and 4).
(A) Statistical distribution (% over the total equilibrated conformations—reported as bar graphs) of anandamide (first row), oleamide (second row), and palmitoylethanolamide (PEA—third row) conformations when located in the MA (red bars), T (cyan bars), and AB (orange bars) regions of the wtFAAH (first column) and mutFAAH (second column) systems. For the mutFAAH/oleamide system, the percentage of unbounded oleamide conformations (NB—not-bound) is also indicated with a green bar. For each system, one representative conformation of the most populated state is shown. The MA (red) and AB (orange) channels are shown in molecular surfaces. Key residues of the FAAH active site are in space-filling representation, namely: Leu192 (gray), Phe194 (ice blue), Phe381 (maroon), Phe432 (green), and Trp531 (violet). Phe432 and Trp531 are mutated in Ala in the mutFAAH systems. The substrates (yellow), as well as the catalytic triad and the oxyanion hole (cyan) are also shown in sticks. (B) Percentages of pre-reactive conformations of anandamide, oleamide, and palmitoylethanolamide (in rows) in the MA, T, and AB regions (in columns) of the wtFAAH and mutFAAH systems. The total percentage of pre-reactive conformations over the production runs is also reported in the last column. A representative picture of pre-reactive conformation is also reported (full details are reported in the S1 Text and in S7 Fig).
Time windows for the substrates location are shown with different background colors: red (MA channel), yellow (AB channel), and cyan (T region). The green background indicates the time windows for the oleamide unbinding in the mut-FAAH. Full details are in the main text, in the S1 Text and in S2 Fig.
Phe432 and Trp531 trigger the MA<–>AB transitions of anandamide, assuming different configurations that open and close the MA channel (Fig 2). This mechanism favors the proper location of pre-reactive conformations of anandamide between the two channels, as evidenced by the polar plot of the φ angles of Phe432 (φF) and Trp531 (φW) with respect to the location of the substrate in pre-reactive states (Fig 5). In detail, for pre-reactive conformations in the MA channel (red plot), the φF (green dots) ranges from ~120° to ~180° with the opening of MA. During the MA<–>AB transfer (cyan plot), the φF shows a bimodal distribution, given the rotation of φF from ~150° (“open” MA channel) to ~60° (“closed” MA channel, as observed in the X-ray structure), which permits the MA<–>AB transfer of the arachidonoyl chain. Trp531 contributes to this transfer, rotating φW by about ~35/40° (magenta dots). When pre-reactive conformations are in AB (yellow plot), Phe432 mainly closes the MA channel (φF ~65°), opening the adjacent AB channel, while Trp531 rotates φW from ~145° to ~180°.
The polar (d-MA, d-T and d-AB) and angular (φ—in red on the plot) coordinates are explicitly indicated on the plots. The approximate values of φF of Phe432 for the “open” and “closed” MA channel configurations are highlighted with blue dashed bars. Distances and angles are expressed in Å and degrees, respectively. Definitions of the d-MA, d-T and d-AB distances are reported in the Methods section. Selected snapshots from MD simulations indicating the “open” (left) and “closed” (right) MA channel configurations, as induced by the rotation of the φ angle of Phe432 and the cooperative Trp531, are shown at the bottom of the polar plots. The MA (red) and AB (orange) channels are represented in molecular surfaces. Phe432 (green) and Trp531 (violet) are shown in space-filling representation. The φ angle of the two residues is explicitly reported.
For the mutant form of FAAH, we detect several MA<–>AB transitions of the arachidonoyl chain (S9 Fig). After equilibration, the percentage of total anandamide conformations within the MA and AB channels is 58% and 37%, respectively, while only 5% of total anandamide conformations are found in the T region (Fig 3). This is primarily due to the absence of van der Waals interactions between the anandamide Δ14 double bond and Phe432 (in this system mutated to Ala), which instead are present in the wt-system. As a result, the arachidonoyl chain is mainly “elongated”, whereas it was mainly “curved” in wtFAAH (Fig 4). As a consequence, pre-reactive conformations are not sampled in the mutFAAH system, as anandamide never locates in the T region assuming the specific “curved” conformations that characterize the pre-reactive states in the wt-system (Figs 3 and 4).
In this system, oleamide reversibly transfers its acyl chain from the MA to the AB channel, resembling the behavior observed for anandamide in the wt-system (Fig 2), although with less frequent transfers. In both enzymatic subunits, Phe432 shows several dihedral transitions, thus assuming two different configurations that lead to the “open” (φF ~160°) and “closed” (φF ~65°—X-ray) MA channel configurations, whereas Trp531 does not undergo any conformational transitions.
After equilibration, the percentage of oleamide conformations within the MA channel is 75%, while the T region and the AB channel are poorly populated (24% and 1%, respectively—Fig 3). Pre-reactive conformations are sampled for 16% of the total equilibrated trajectory, therefore much less than for anandamide. The 78% of these conformations are located in the MA channel, 21% in the T region, and only a few are sampled in the AB channel (1%—Fig 3). The different preferential location for oleamide in MA, compared to anandamide, can be explained by the presence of only one double bond (Δ9) of the oleoyl chain, which results in weaker interactions with the aromatic residues Phe381/Phe432 (Fig 3). This also explains the formation of “hooked” configurations of the oleoyl chain (Fig 4).
When oleamide is in a pre-reactive state and located in MA, φF shows a bimodal distribution (red plot in Fig 5B—φF angle is shown in green dots), therefore opening (φF ~180°) and closing (φF ~60°) the MA channel. This bimodal behavior of the dynamic paddle mechanism (which is similarly detected for pre-reactive conformations in T and AB) allows the proper location of the shorter oleoyl chain in the MA channel, via the formation of van der Waals interactions with the Δ9 double bond of the lipid and Phe432 (Fig 3).
During the simulations, oleamide never transfers its acyl chain from the MA channel into the adjacent AB channel (S9 Fig). This explains that 70% of the total oleamide configurations are located in the MA channel, while only a few conformations of the lipid are located in the T region (3%) and no conformations are detected in the AB channel (Fig 3). When located within the mutFAAH active site, oleamide is preferentially “elongated”, as the oleoyl acyl chain is not bent by Phe432 (Fig 4). As in the mutFAAH/anandamide system, pre-reactive conformations are not sampled for oleamide in complex with the mutFAAH protein. This highlights the crucial role of the Phe432/Trp531 gating residues in inducing specific conformations for hydrolysis of these lipids.
Interestingly, oleamide spontaneously unbinds from the FAAH active site and locates within the lipid bilayer for 27% of the overall production run. Oleamide unbinding occurs in both FAAH subunits (at ~425 ns in mnr-A and at ~350 ns in mnr-B) and via the same mechanism. As previously suggested,[1,7,25] two charged residues (Asp403–Arg486) facilitate the passage of the substrate through the MA channel, H-bonding to the polar head group of the substrate (S10 Fig). Surrounded by lipids, oleamide mainly assumes “hooked” conformations (Fig 4), in agreement with the proposal that FAAH substrates need to adopt a closed “hairpin-like” conformation to be transported across the membranes.[57,58] The mutation of Phe432, which in the wt-system interacts with the oleamide Δ9 double bond, causes a destabilization of the oleoyl chain within the active site. In addition, oleamide is a primary amide that, therefore, does not have the ability to form H-bond interactions with the CP residue Thr236, which is critical for leaving group departure, after substrate hydrolysis.[1,7,25] A detailed description of oleamide unbinding in the mutFAAH protein is reported in S1 Text and S10 Fig.
The lipid remains mainly located in the MA channel in both the enzyme subunits, for the whole simulation time (Fig 2C) and no MA<->AB transfers of the PEA acyl chain occur. Phe432 assumes different conformations via the rotation of φF from ~65° to ~160°, allowing an optimal fit of the long palmitoyl chain into the MA channel. Trp531 does not undergo dihedral transitions during the simulation, further stabilizing the palmitoyl chain in the MA channel.
After the equilibration time, 91% of the total PEA configurations are located in the MA channel and 9% locate in the T region (Fig 3). Pre-reactive conformations are observed for 11% of the production run. Most of these conformations are located in the MA channel (86%), whereas fewer conformations locate in the T region (14%, Fig 3), and none in AB. The palmitoyl tail preferentially assumes “elongated” shapes (Fig 4), given the absence of unsaturation within the lipid. This prevents PEA from establishing specific interactions with Phe381/Phe432 and catalyzing the MA<–>AB switch, which is similar to the process observed with oleamide and anandamide. Therefore, the lipid acyl chain does not undergo any bending, which explains the fully elongated shapes and the absence of MA<–>AB transfers.
Here, PEA transfers its palmitoyl chain from the MA to the AB channel in the early phase of the equilibration (~10/20 ns), in both FAAH monomers (S9 Fig). After equilibration, conformations of PEA detected within the MA channel are statistically irrelevant (0%), whereas 5% of PEA conformations are located in the T region and 95% within the AB channel (Fig 3). The lipid remains anchored to the end of the AB channel throughout the simulations, strongly interacting with Tyr225 and Phe527. Meanwhile, the head of the substrate is H-bonding with Thr236 at the top of the active site. These interactions favor the formation of “elongated” conformations (Fig 4).
Pre-reactive conformations are sampled for 15% over the whole production run. Most of the pre-reactive conformations are sampled when the palmitoyl acyl chain is located in the AB channel (84%) and in the T region (16%). These conformations are not sampled in the MA channel (Fig 3B).
Enzyme kinetic experiments
To further characterize the proposed mechanism for substrate selection during FAAH catalysis, we expressed and purified the recombinant wt rat FAAH protein (MBP-rFAAH-6xHis construct) and we also introduced a single point mutation for each of the two paddle residues (Phe432Ala and Trp531Ala). The activity of the purified wt and two mutant proteins was tested using enzyme kinetic experiments in the presence of different concentrations of each substrate (anandamide and PEA), as reported in the method section. The enzymatic reactions were quenched after 30 minutes when a steady-state equilibrium was reached (i.e., Michaelis Menten condition).
The Km value obtained for the wt protein in the presence of the anandamide substrate was equal to 5.26 μM, in excellent agreement with the results reported by Labar G. et al. (Km = 5.31 μM) for the recombinant MBP-FAAH construct. The overlay of the kinetic curves obtained for anandamide shows that the enzyme velocity (pmol of substrate consumed per minute per μg of protein) is only slightly higher for the wt protein compared to the two mutant proteins (Table 1). Thus, neither of the two mutations seems to significantly affect the affinity of FAAH for the anandamide substrate under steady-state conditions. With the PEA substrate, we find an enzyme affinity that is 2-fold lower then the one for anandamide, with a Km equal to 12.53 μM for the wt protein. Here too, each of the two mutations only marginally affects the affinity of the enzyme for the PEA substrate (Km values in Table 1). Overall, steady-state conditions confirm that FAAH has better affinity for anandamide, over PEA, for wtFAAH.
We further performed competition experiments under non-equilibrium conditions, which is often reported to be the case for biochemical reactions in vivo.[60–62] These are performed on a mixture of the three proteins, i.e. the wtFAAH and the two Phe432Ala and Trp531Ala mutants, in the presence of both anandamide and PEA. The enzymatic reaction was quenched at different time points, within the initial 30 minutes of reaction, and the products were then analyzed by UPLC-MS/MS (see Methods section).
As reported in Fig 6, for the wtFAAH recombinant protein, the rate of anandamide hydrolysis is 5.6 times faster than for PEA (S6 Table in S2 Text). Single point mutants (Phe432Ala and Trp531Ala) showed similar decay rates for both anandamide and PEA substrates (Fig 6 and S6 Table in S2 Text).
Each set of data was fitted using simple exponential decay functions, whose parameters are reported in S6 Table in S2 Text.
We also tested the validity of our competition assay, described in the Methods section, on a rat liver microsomes preparation. As expected, we found that FAAH preferentially cleaves its main substrate, anandamide, rather than PEA (S11 Fig; S7 Table in S2 Text) in rat liver microsomes. This is in agreement with Desarnaud et al., who reported that the FAAH hydrolytic function is more efficient for anandamide than for PEA in rat brain microsomes. A consistently faster rate of hydrolysis for anandamide, compared to PEA, was observed in both the recombinant form of FAAH and in rat liver microsomes. This suggests that the microsomal membrane may not critically affect substrate selectivity in FAAH catalysis.
Extensive classical molecular dynamics simulations have been coupled with mutagenesis and kinetic experiments to understand the enzymatic mechanism for substrate selectivity of FAAH, which hydrolyzes a variety of lipids with however different catalytic rates. We correlated the dynamics of FAAH with its experimental activity, when in complex with anandamide, the primary substrate of FAAH, and two less efficiently hydrolyzed substrates, oleamide and palmitoylethanolamide (PEA). The dynamic paddle residues Phe432 and Trp531 have been hypothesized to regulate both selectivity and activity of FAAH.[7,25] To better dissect their specific role, we considered wild-type (wt) and mutated Phe432Ala and Trp531Ala systems, both in MD and in single-point mutagenesis experiments.
During the MD simulations of the wtFAAH systems, we detected a different preferential location of the three substrates (anandamide, oleamide, and PEA) within the enzymatic active site. Importantly, the exact location of the substrate is strictly related to the presence/absence of double bonds within the lipid chain (Figs 2 and 3). Along the MD runs, the substrate population in the transition (T) region, which indicates MA<–>AB transfers, increases according to the number of double bonds located in the acyl chain of the substrate. Anandamide (4 C = C) locates in the T region for 69% of the simulation time, while only 24% of oleamide conformations and 9% of PEA conformations are sampled in the T region. This indicates that the four unsaturations in anandamide form favorable van der Waals interactions with the gating residue Phe432, explaining why anandamide is mostly located in the T region. This hydrophobic interaction is less pronounced with oleamide (one C = C), and not possible with PEA (no C = C).
In the T region, both anandamide and oleamide undergo a conformational change that favors their interaction with the gating Phe432 residue. As a result, the acyl chain of those unsaturated substrates is bent in the T region, in the wtFAAH active site (Fig 4). In this way, the substrate is properly located for hydrolysis, forming pre-reactive conformations, i.e. conformations more prone to undergoing hydrolysis. Therefore, the presence of unsaturations seems a pre-requisite for efficient substrate hydrolysis. Importantly, this would explain why the rate for substrate hydrolysis increases with the number of double bonds of the substrate lipid chain, as observed in previously published experimental data.[9,10] The time-dependent hydrolysis of linolenoyl (3 C = C) substrates is 45:100 times slower than anandamide, while eicosadienoyl (2 C = C), oleoyl (1 C = C) and the palmitoyl chains (no C = C) substrates are hydrolyzed, respectively, at rates 35:100, 2:100, and 1:100 times slower than anandamide. Also, Boger et al. have shown that the incorporation of π-unsaturations at the arachidonoyl Δ8,9/Δ1,12 and oleoyl Δ9,10 locations into several α-ketoheterocycles inhibitors greatly enhances the potency of those compounds, suggesting that bent conformations of the ligand are essential for tight binding to FAAH.[9,64] Anandamide forms the highest percentage of pre-reactive conformations compared to the other substrates. In fact, pre-reactive conformations are differentially sampled by each substrate (wtFAAH/anandamide 27%, wtFAAH/oleamide 16%, and wtFAAH/PEA 11%). Binding free energies (ΔGBind—see Methods section, S1 Text and S4 Table in S2 Text), obtained via the MM/PBSA method,49,50 confirm the highest affinity of anandamide for the wtFAAH. Oleamide’s affinity for FAAH is ~5 kcal mol-1 lower than that found for anandamide. PEA shows ~11 kcal mol-1 lower affinity for FAAH, compared to anandamide. This further suggests that the van der Waals interaction between the substrate unsaturations of anandamide and the Phe432 side chain at the T region can favor binding and catalysis.
MD simulations show that in the mutFAAH double mutant, anandamide preferentially locates in the MA channel. Due to the absence of the key interface Phe432/Trp531 residues, and rarely locates itself in the T region (Fig 3). As a result, pre-reactive conformations are not sampled in the mutFAAH/anandamide, which is similar to observations for the mutFAAH/oleamide. Notably, in wtFAAH/PEA and mutFAAH/PEA, pre-reactive conformations are observed for 11% and 15% of the production runs, respectively. These data indicate that the presence/absence of the dynamic paddle does not significantly affect the formation of PEA pre-reactive conformations in FAAH. In the case of the unsaturated lipids—i.e., anandamide and oleamide—the presence of the dynamic paddle is crucial in determining the formation of catalytically competent states of the complex. In fact, pre-reactive conformations are not observed in the mutFAAH/anandamide and mutFAAH/oleamide systems. These data further suggest the dynamic paddle as crucial in selecting the pre-reactive states for the hydrolysis of the unsaturated lipids in FAAH[9, 10]. Moreover, “elongated” conformations of PEA are sampled in both the wt and mut FAAH systems (Fig 4). The lack of unsaturations in the substrate’s tail explains the similar behavior of PEA in wt and mut systems, further corroborating the specificity of the paddle residues for unsaturated lipids only, such as anandamide. Taken together, these results indicate that, in the absence of the dynamic paddle, or in the absence of unsaturations in the substrate’s tail, the ligand does not assume “curved” (anandamide) and “hooked” (oleamide) conformations at the T region in the catalytic pocket. Notably, these conformations characterize the pre-reactive states in wtFAAH, indicating that curved and hooked conformations are probably catalytically relevant for FAAH-mediated hydrolysis.
Mutagenesis and enzyme kinetic experiments, performed using anandamide and PEA, further confirm the importance of the dynamic paddle mechanism for substrate selection in FAAH, especially using competition assays in non-equilibrium conditions. In fact, in wtFAAH, the Km for anandamide is 2-fold higher than for PEA (Table 1).[9,10] In steady-state conditions, however, the single mutations of the two paddle residues did not significantly affect the enzyme kinetic parameters. Nevertheless, when we performed competition assays in non-equilibrium conditions, we observed that FAAH had a larger affinity for anandamide than for PEA. In this case, the rate of hydrolysis for anandamide was 5.6 times faster than for PEA after 30 mins, measured for the wtFAAH recombinant protein (S6 Table in S2 Text), while much higher in the very first 5 mins (see Fig 6A), as observer in Desarnaud et al. When single point mutations (Phe432Ala or Trp531Ala) were inserted, results showed similar decay rates for both anandamide and PEA substrates, further suggesting the paddle mechanism as a key to substrate selectivity.
The experimental single point mutations were also able to discern the contribution to the paddle mechanism of each one of the two key residues Phe432 and Trp531. In fact, the mutations Phe432Ala and Trp531Ala show that the two residues Phe432 and Trp531 affect the paddling mechanism differently. The Trp531Ala mutation preserves the decay rate of anandamide, as observed in the wt protein, while the Phe432Ala mutant induces a hydrolysis rate of anandamide that is two times slower than the wt protein (S6 Table in S2 Text). This suggests a predominant role of the gating Phe432 residue in the paddle mechanism for lipid selection and substrate hydrolysis. This agrees with our MD simulations, which indicate Phe432 as the main player in the formation of specific “curved” pre-reactive conformations of anandamide (Fig 4). Phe432 primarily mediates the mutual opening and closure of the MA and AB channels through a gating mechanism, allowing a proper location of the unsaturated chains for hydrolysis (Fig 5), while Trp531 mostly exerts a cooperative role in this process. PEA is also hydrolyzed twice as fast by Trp531Ala and more than four times as fast by Phe432Ala when compared to the wt, further suggesting that the paddle mechanism is only selective for anandamide (Fig 6). This is in very good agreement with our computational findings. As reported above, we detect a higher occurrence of pre-reactive conformations of PEA in mutFAAH (15%) with respect to wtFAAH (11%), while the calculated binding free energy (ΔGBind) of PEA to mutFAAH is ~7 kcal mol-1 higher than the one for wtFAAH (see S1 Text and S4 Table in S2 Text).[50,51]
Interestingly, it has recently been suggested that the membrane itself may have a role in supporting substrate entrance towards the catalytic site, somehow helping substrate selectivity. In this respect, we also performed kinetics experiments in rat liver microsomes, confirming the evidence obtained by Desarnaud et al. in rat brain microsomes, with FAAH preferentially hydrolyzing its main substrate anandamide, compared to PEA (S11 Fig; S7 Table in S2 Text). These findings are in agreement with our experiments on substrate selectivity performed using the recombinant in vitro protein in the absence of membranes. We used a transmembrane domain-deleted FAAH construct, which was still catalytically active and able to bind the membranes, as reported by Patricelli et al. The substrate selectivity, observed in the microsomes, is similar to that observed for the recombinant form. This suggests that the membrane’s contribution is not likely to significantly affect the mechanism for substrate selectivity in FAAH.
The idea that the selective binding of long and flexible lipid substrates to lipid-processing enzymes could be facilitated by the presence of multiple pockets in one catalytic site, as described here, is also supported by several other pieces of experimental data. Crystallographic and biochemical studies have suggested that FAAH could adapt to the chemical nature of different lipid substrates or inhibitors thanks to a pronounced flexibility of its binding channels.[34,56,65,67–70] A mix of hydrophobic/hydrophilic pockets, similar to that found in FAAH, was also found in the active site of another endocannabinoid enzyme MAGL, which primarily hydrolyzes the endocannabinoind 2-arachidonoylglycerol (2-AG, Fig 7A). MAGL’s catalytic site shows a long and bipartite acyl-chain channel that faces the membrane, likely allowing the entrance of the flexible lipid chain of 2-AG from the lipid bilayer. This channel hosts two Phe residues (i.e., 93 and 209), which, similarly to the dynamic paddle mechanism observed in FAAH, could assist the binding of the arachidonoyl chain within the catalytic site during catalysis. Indeed, docking studies showed that 2-AG might differentially locate its arachidonoyl chain with respect to Phe93 and Phe209, thus suggesting a possible gating role of those residues in selecting specific conformations of 2-AG into the catalytic pockets. An additional polar cavity is located at the top of the active site and likely accommodates the glycerol head group of 2-AG for subsequent hydrolysis.[4,8] Finally, a third binding cavity in MAGL, an opening with a diameter of ~5 Å connects the active site to the outside of the protein, ensuring the leaving group departure, similarly to the CP cavity in FAAH.
(A) Active site of the apo form of monoacylglycerol lipase (MAGL –3HJU.pdb). A long acyl-chain channel (orange) is supposed to accommodate the arachidonoyl chain of 2-arachidonoylglycerol (2-AG), thanks to the presence of the aromatic Phe93 (green) and Phe209 (magenta). At the top of the active site, a polar cavity (red) likely accommodates the glycerol head group of 2-AG, as a glycerol molecule (yellow sticks) has been crystallized in this region. A third cavity (cyan) is thought to allow the exit of the substrate leaving group, after hydrolysis. The Ser122–Asp239–His269 catalytic triad is also shown with cyan sticks. (B) Superimposition of the cyclooxygenase COX-2 in complex with the arachidonic acid substrate (yellow— 1DIJ.pdb) and with the prostaglandin H2 (PGH2) product (cyan— 1DDX.pdb). The catalytic Tyr385 is in dark green when in the presence of arachidonic acid and light green when in the presence of PGH2. It shows a conformational change that opens the gate from the cyclooxygenase to the peroxidase active site. For clarity, the key Trp387 (magenta), Phe381 (maroon), and Phe209 (ice blue) are only shown for the 1DIY.pdb. The heme co-factor is also shown. The cyclooxygenase and peroxidase active sites are in gray molecular surface. (C) Active site of the human fatty acid synthase (FAS) covalently bound to the methyl γ-linolenylphosphonate substrate (yellow— 3TJM.pdb) and to the antitumor drug Orlistat (cyan— 2PX6.pdb). In the presence of the γ-linolenyl chain, Tyr2343 (light green) forms a “gatekeeper helix” with Tyr2351 (magenta) and Tyr2347 (sky blue), leading to the formation of a long groove tunnel for the selective binding of the linolenyl chain. When bound to Orlistat, Tyr2351 (dark green) is buried within the active site, causing the loss of the “gatekeeper helix” mechanism, which is not formed. Tyr2351 (magenta) and Tyr2347 (ice blue), as well as the “gatekeeper helix” (violet ribbons), are only shown for the 3YJM.pdb. The protein active site is in gray molecular surface.
It is interesting to consider the catalytic site architecture of other lipid-degrading enzymes that show structural features, similar to FAAH, which might be required for substrate selection. The first examples are the cyclooxygenase COX-1 and COX-2 enzymes, which specifically transform the product of FAAH catalysis (the arachidonic acid) into prostaglandin H2 (PGH2) via two sequential reactions that occur in two spatially distinct active sites (Fig 7).[71,72] Interestingly, X-ray structures of COXs show that the interaction between the arachidonoyl tail of the substrate and the aromatic Tyr385, Trp387, Phe209, and Phe381 residues leads to specific conformations of the arachidonic acid, which sensibly differ from those of other fatty acids that are processed with lower catalytic efficiency.[71–73] The human fatty acid synthase (FAS) is a further example of a lipid-processing enzyme that shows flexible binding channels and gating residues. FAS is responsible for the de novo biosynthesis of long-chain fatty acids. In this case, high-resolution crystal structures show that the covalently bound γ-linolenyl substrate selectively binds in a long groove tunnel site. It has been suggested that this makes the selection for the C18 substrates (Fig 7). The comparison between the active site region of FAS covalently bound to either the γ-linolenyl substrate (C18 and 3 C = C) or to the antitumor drug Orlistat (characterized by the saturated palmitic chain) shows a conformational change of Tyr2343, again suggesting a possible gating mechanism for lipid selection. Upon γ-linolenyl substrate binding, Tyr2343 forms a “gatekeeper helix” with Tyr2351 and Tyr2347 that is not observed in the presence of Orlistat. Finally, multiple channels in a single active site are also reported in other lipid-degrading enzymes, such as lipase hydrolyzing triglycerides, which show varying substrate specificity for different lipid acyl chains. This seems to depend on the shape and length of the fatty acid binding cavity.,
Overall, these data suggest that structural flexibility, gating residues, and multiple binding pockets are key to lipid selection in FAAH catalysis and, probably, in other structurally similar lipid-degrading enzymes. The concomitant existence of these structural features seems crucial to facilitating the preferential binding of the selected lipid within a broad spectrum of endogenous molecules. In FAAH, the interplay between the ligand and protein structural flexibility seems crucial to understanding the lipid selection mechanism, as mediated by key gating residues that form the dynamic paddle. Finally, we have shown that this structural framework for lipid selection could probably be further extended to several other lipid-processing enzymes.
Here, long time-scale classical molecular dynamics simulations have been integrated with mutagenesis and kinetic experiments in order to clarify the molecular basis for substrate selectivity in FAAH catalysis. Extensive MD simulations of FAAH in complex with its main substrate anandamide have been compared with simulations where FAAH is in complex with less efficiently hydrolyzed substrates (oleamide and palmitoylethanolamide). This comparative study has revealed that FAAH selectively accommodates anandamide into a multi-pocket binding site, and properly orients it in pre-reactive conformations for efficient hydrolysis. Mutagenesis and kinetic experiments have further highlighted the importance of Phe432 and Trp531 for substrate selection in competition assays in non-equilibrium conditions. The interplay between ligand and protein structural flexibility seems crucial for lipid selection during catalysis in FAAH, as mediated by the gating residues Phe432 and Trp531 that form the dynamic paddle, which facilitates the formation of pre-reactive conformations of the substrate/enzyme complex.
Based on existing structural data, we propose that our results could be extended to other lipid-processing enzymes where the presence of multiple binding cavities and gating residues have been indicated to be relevant for enzyme selectivity and function. One example is MAGL, another endocannabinoid enzyme, which primarily hydrolyzes 2-arachidonoylglycerol. A broader validation of this structural framework for lipid selection, with additional experimental and/or theoretical investigations, would be very informative and applicable to de-novo enzyme design and drug discovery efforts.
S1 Fig. Initial conformation of the studied substrates anandamide (A), oleamide (B) and PEA (C) within the wtFAAH active site (PDB code: 1MT5).
Residues belonging to the MA (red) and AB (orange) channels are shown in molecular surfaces. Phe432 (green) and Trp531 (violet) are shown in space-filling representation. The substrates (yellow) and the Ser241-Ser217-Lys142 catalytic triad (cyan) are shown as sticks.
S2 Fig. Chemical structure (top) and conformations (bottom) of anandamide (A), oleamide (B) and PEA (C).
Anandamide conformations are classified in three classes: (i) class of the “elongated” shapes that include the extended Ex and extended U Uex shapes; (ii) class of the “hooked” shapes including the J and J’ shapes; (iii) class of the “curved” shapes comprising the U, helical Hx and the half helical Hx-A/B shapes. Oleamide conformations are classified as “elongated” (Ex), “hooked” (J/J’) and “curved” (Hx), as well. PEA conformations are “extended” Ex, “hooked” J and “helical” Hx conformations. The lipids are depicted in yellow sticks. Torsion angles ω used to define the lipid conformations are highlighted in red, blue, and green colors. Details are reported in S1 Text.
S3 Fig. RMSD of the protein along MD simulations of the wtFAAH systems.
Time evolution of the RMSD for the backbone atoms of the overall FAAH protein (blue), the crystallographic residues [30–597 (red)] and the modeled trans membrane residues [1–29 (green)], shown for the wtFAAH/anandamide (upper graph), the wtFAAH/oleamide (central graph) and the wtFAAH/PEA (lower graph) systems. The gray background indicates the equilibration time (~150 ns).
S4 Fig. RMSD of the protein along MD simulations of the mutFAAH systems.
Color code as S3 Fig.
S5 Fig. RMSD of the ligands along MD simulations of the wtFAAH systems.
Time evolution of the RMSD for the heavy atoms of the anandamide, oleamide and PEA substrates in monomer-A (blue) and monomer-B (red) of the wtFAAH/anandamide (upper graph), the wtFAAH/oleamide (central graph) and the wtFAAH/PEA (lower graph) systems. Averages are shown in corresponding solid lines. The gray background indicates the equilibration time (~150 ns).
S6 Fig. RMSD of the ligands along MD simulations of the mutFAAH systems.
Color code as S5 Fig.
S7 Fig. Definition of catalytically significant conformations.
Distances (A) and angles (B) used to define the catalytically significant conformations in the FAAH/substrates complexes, shown for the anandamide substrate.
S8 Fig. Location of the substrates acyl chain in the wtFAAH systems.
Time evolution of the minimum distances between the last three atom of the substrates acyl chain and the residues belonging to the MA channel (red), AB channel (orange) and to the MA/AB interface region [i.e., T region (blue)], shown for monomer-A (Mnr-A, first column) and monomer-B (Mnr-B, second column) of the wtFAAH/anandamide (upper graph), the wtFAAH/oleamide (central graph) and the wtFAAH/PEA (lower graph) systems. Averages are shown in corresponding solid lines. The g-mindist tool present in the GROMACS 4 package for MD analysis was used. The gray background indicates the equilibration time of the systems. Time windows for the location of the substrates are indicated with different color backgrounds: red (MA channel), yellow (AB channel) and cyan (MA/AB interface).
S9 Fig. Location of the substrates acyl chain in the mutFAAH systems.
Color code as S8 Fig.
S10 Fig. Unbinding mechanism of oleamide in the mutFAAH systems.
In the mutFAAH/oleamide system, oleamide spontaneously unbinds from the FAAH active site using the MA channel as an exit route. The unbinding mechanism is favored by two charged residues of the MA channel (Asp403 and Arg486, which are shown in cyan sticks) that facilitate the passage of the substrate through the MA channel, H-bonding to the polar head group of the substrate. The oleamide unbinding occurs in both FAAH monomers (at ~425 ns in mnr-A and at ~350 ns in mnr-B). The MA (red) and AB (orange) channels are depicted in molecular surface representation. The mutated “dynamic paddle” residues Ala432 (green) and Ala531 (green) are shown in space-filling representation. The enzymatic framework is shown in gray ribbons, while the lipids of the membrane are represented in cyan lines. Water molecules accessing the MA channel are also shown as sticks and balls.
S11 Fig. Competition assays performed for a rat liver microsome preparation in the presence of both substrates anandamide (black) and PEA (red).
The reactions were quenched at different time points with the addition of four volumes of cold acetonitrile. Each set of data was fitted using simple exponential decay functions, whose parameters are reported in S7 Table in S2 Text.
S12 Fig. Kinetic experiments showing the rate of hydrolysis of the anandamide and PEA substrates for the wt enzyme (black), the F432A mutant (red), and the W531A mutant (blue).
Reaction was stopped after 30 minutes at 37°C assuming that a steady state was reached (Michaelis Menten condition). Each set of data was fitted using a Michaelis Menten model. Details are reported in the main text.
S13 Fig. Graphical representation of the main message of this work.
S1 Text. Supporting Text section.
Full docking details. Details on the conformational analysis of the lipid substrates. Definition of catalytically competent conformational states of the FAAH/substrate complexes. Reproducibility of the results in both FAAH subunits. Details on the location of the substrates within FAAH active site during MD. Details on the occurrence of pre-reactive conformational states during MD. Unbinding of oleamide in the mutFAAH system. Binding free energy calculations.
S2 Text. Supporting Information including S1–S7 Tables.
(DOCX) Supporting tables including docking data (S1 Table), statistical analysis of the occurrence of catalytically relevant conformations (S2-S3 Tables), binding free energies (ΔGBind—S4 Table) and ΔGBind energetic contributions (S5 Table). Supporting data about competition assays are also reported (S6-S7 Tables).
Conceived and designed the experiments: GP AA SG UR MDV. Performed the experiments: GP IB AA. Analyzed the data: GP IB PC AC AA SG UR MDV. Wrote the paper: GP SG UR MDV.
- 1. Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF (2002) Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298: 1793–1796. pmid:12459591 doi: 10.1126/science.1076535
- 2. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, et al. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83–87. pmid:8900284 doi: 10.1038/384083a0
- 3. Giang DK, Cravatt BF (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci U S A 94: 2238–2242. pmid:9122178 doi: 10.1073/pnas.94.6.2238
- 4. Labar G, Bauvois C, Borel F, Ferrer JL, Wouters J, et al. (2010) Crystal structure of the human monoacylglycerol lipase, a key actor in endocannabinoid signaling. ChemBiochem 11: 218–227. doi: 10.1002/cbic.200900621. pmid:19957260
- 5. Ahn K, McKinney MK, Cravatt BF (2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108: 1687–1707. doi: 10.1021/cr0782067. pmid:18429637
- 6. Di Marzo V (2009) The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol Res 60: 77–84. doi: 10.1016/j.phrs.2009.02.010. pmid:19559360
- 7. McKinney MK, Cravatt BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74: 411–432. pmid:15952893 doi: 10.1146/annurev.biochem.74.082803.133450
- 8. Labar G, Wouters J, Lambert DM (2010) A Review on the Monoacylglycerol Lipase: At the Interface Between Fat and Endocannabinoid Signalling. Curr Med Chem 17: 2588–2607. pmid:20491633 doi: 10.2174/092986710791859414
- 9. Boger DL, Fecik RA, Patterson JE, Miyauchi H, Patricelli MP, et al. (2000) Fatty acid amide hydrolase substrate specificity. Bioorg Med Chem Lett 10: 2613–2616. pmid:11128635 doi: 10.1016/s0960-894x(00)00528-x
- 10. Desarnaud F, Cadas H, Piomelli D (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem 270: 6030–6035. pmid:7890734 doi: 10.1074/jbc.270.11.6030
- 11. Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, et al. (2009) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A 106: 20270–20275. doi: 10.1073/pnas.0909411106. pmid:19918051
- 12. Otrubova K, Brown M, McCormick MS, Han GW, O'Neal ST, et al. (2013) Rational Design of Fatty Acid Amide Hydrolase Inhibitors That Act by Covalently Bonding to Two Active Site Residues. J Am Chem Soc 135: 6289–6299. doi: 10.1021/ja4014997. pmid:23581831
- 13. Bertolacci L, Romeo E, Veronesi M, Magotti P, Albani C, et al. (2013) A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase. J Am Chem Soc 135: 22–25. doi: 10.1021/ja308733u. pmid:23240907
- 14. Favia AD, Habrant D, Scarpelli R, Migliore M, Albani C, et al. (2012) Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor. J Med Chem 55: 8807–8826. doi: 10.1021/jm3011146. pmid:23043222
- 15. Otrubova K, Cravatt BF, Boger DL (2014) Design, Synthesis, and Characterization of alpha-Ketoheterocycles That Additionally Target the Cytosolic Port Cys269 of Fatty Acid Amide Hydrolase. J Med Chem 57: 1079–1089. doi: 10.1021/jm401820q. pmid:24456116
- 16. Lambert DM, Fowler CJ (2005) The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J. Med. Chem. 48: 5059–5087. pmid:16078824 doi: 10.1021/jm058183t
- 17. Hernandez-Torres G, Cipriano M, Heden E, Bjorklund E, Canales A, et al. (2014) A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis. Angew Chem Int Ed Engl 53: 13765–13770. doi: 10.1002/anie.201407807. pmid:25298214
- 18. Makriyannis A (2014) 2012 division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective. J Med Chem 57: 3891–3911. doi: 10.1021/jm500220s. pmid:24707904
- 19. Boger DL, Miyauchi H, Du W, Hardouin C, Fecik RA, et al. (2005) Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics. J Med Chem 48: 1849–1856. pmid:15771430 doi: 10.1021/jm049614v
- 20. Guimaraes CR, Boger DL, Jorgensen WL (2005) Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations. J Am Chem Soc 127: 17377–17384. pmid:16332087 doi: 10.1021/ja055438j
- 21. Lodola A, Capoferri L, Rivara S, Tarzia G, Piomelli D, et al. (2013) Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors. J Med Chem 56: 2500–2512. doi: 10.1021/jm301867x. pmid:23425199
- 22. Lodola A, Mor M, Hermann JC, Tarzia G, Piomelli D, et al. (2005) QM/MM modelling of oleamide hydrolysis in fatty acid amide hydrolase (FAAH) reveals a new mechanism of nucleophile activation. Chem Commun (Camb): 4399–4401. doi: 10.1039/b503887a
- 23. Palermo G, Branduardi D, Masetti M, Lodola A, Mor M, et al. (2011) Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas. J Med Chem 54: 6612–6623. doi: 10.1021/jm2004283. pmid:21830831
- 24. Palermo G, Campomanes P, Cavalli A, Rothlisberger U, De Vivo M (2015) Anandamide Hydrolysis in FAAH Reveals a Dual Strategy for Efficient Enzyme-Assisted Amide Bond Cleavage via Nitrogen Inversion. J Phys Chem B 119: 789–801. doi: 10.1021/jp5052276. pmid:25205244
- 25. Palermo G, Campomanes P, Neri M, Piomelli D, Cavalli A, et al. (2013) Wagging the Tail: Essential Role of Substrate Flexibility in FAAH Catalysis. J. Chem. Theory comput. 9: 1202–1213. doi: 10.1021/ct300611q
- 26. Palermo G, Rothlisberger U, Cavalli A, De Vivo M (2015) Computational insights into function and inhibition of fatty acid amide hydrolase. Eur J Med Chem 16: 15–26 doi: 10.1016/j.ejmech.2014.09.037
- 27. Tubert-Brohman I, Acevedo O, Jorgensen WL (2006) Elucidation of hydrolysis mechanisms for fatty acid amide hydrolase and its Lys142Ala variant via QM/MM simulations. J Am Chem Soc 128: 16904–16913. pmid:17177441 doi: 10.1021/ja065863s
- 28. Lodola A, Capoferri L, Rivara S, Chudyk E, Sirirak J, et al. (2011) Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling. Chem Commun (Camb) 47: 2517–2519. doi: 10.1039/c0cc04937a. pmid:21240393
- 29. Lodola A, Mor M, Rivara S, Christov C, Tarzia G, et al. (2008) Identification of productive inhibitor binding orientation in fatty acid amide hydrolase (FAAH) by QM/MM mechanistic modelling. Chem Commun (Camb): 214–216. doi: 10.1039/b714136j
- 30. Lodola A, Mor M, Sirirak J, Mulholland AJ (2009) Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling. Biochem Soc Trans 37: 363–367. doi: 10.1042/BST0370363. pmid:19290863
- 31. Lodola A, Mor M, Zurek J, Tarzia G, Piomelli D, et al. (2006) Conformational Effects in Enzyme Catalysis: Reaction via a High Energy Conformation in Fatty Acid Amide Hydrolase. Biophys J 15: L20–L22. doi: 10.1529/biophysj.106.098434
- 32. Lodola A, Sirirak J, Fey N, Rivara S, Mor M, et al. (2010) Structural Fluctuations in Enzyme-Catalyzed Reactions: Determinants of Reactivity in Fatty Acid Amide Hydrolase from Multivariate Statistical Analysis of Quantum Mechanics/Molecular Mechanics Paths. J Chem Theory Comput 6: 2948–2960. doi: 10.1021/ct100264j
- 33. Dainese E, De Fabritiis G, Sabatucci A, Oddi S, Angelucci CB, et al. (2014) Membrane lipids are key modulators of the endocannabinoid-hydrolase FAAH. Biochem J 457: 463–472. doi: 10.1042/BJ20130960. pmid:24215562
- 34. Mileni M, Johnson DS, Wang Z, Everdeen DS, Liimatta M, et al. (2008) Structure-guided inhibitor design for human FAAH by interspecies active site conversion. Proc Natl Acad Sci U S A 105: 12820–12824. doi: 10.1073/pnas.0806121105. pmid:18753625
- 35. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, et al. (1998) Automated Docking Using a Lamarckian Genetic Algorithm and and Empirical Binding Free Energy Function J Comput Chem 19: 1639–1662. doi: 10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b
- 36. White DA, Ansell GD, Hawthororne JN, Dawson RMC (1973) Form and Function of Phospholipids. Elsevier, New York.
- 37. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79: 926–935. doi: 10.1063/1.445869
- 38. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25: 1157–1174. pmid:15116359 doi: 10.1002/jcc.20035
- 39. Bayly CI, Cieplak P, Cornell WD, Kollman PA (1993) A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. J Phys Chem 97: 10269–10280. doi: 10.1021/j100142a004
- 40. Hess G, Bekker H, Berendsen HJC, Fraaije JGEM (1997) Lincs: A linear constraint solver for molecular simulations. J Comput Chem 18: 1463–1472. doi: 10.1002/(sici)1096-987x(199709)18:12<1463::aid-jcc4>3.0.co;2-h
- 41. Van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, et al. (2005) Gromacs: Fast, flexible and free. J Comput Chem 26: 1701–1718. pmid:16211538 doi: 10.1002/jcc.20291
- 42. Hoover WG (1985) Canonical dynamics—Equilibrium phase-space distributions. Phys Rev A 31: 1695–1697. pmid:9895674 doi: 10.1103/physreva.31.1695
- 43. Nose S (1986) An extension of the canonical ensemble molecular-dynamics method. Mol Phys 57: 187–191. doi: 10.1080/00268978600100141
- 44. Parrinello M, Rahman A (1981) Polymorphic transitions in single-crystals—A new molecular-dynamics method. J Appl Phys 52: 7182–7190. doi: 10.1063/1.328693
- 45. Palermo G, Stenta M, Cavalli A, Dal Peraro M, De Vivo M (2013) Molecular Simulations Highlight the Role of Metals in Catalysis and Inhibition of Type II Topoisomerase. J Chem Theory Comput 9: 857–862. doi: 10.1021/ct300691u
- 46. Palermo G, Cavalli A, Klein ML, Alfonso-Prieto M, Dal Peraro M, et al. (2015) Catalytic metal ions and enzymatic processing of DNA and RNA. Acc Chem Res 48: 220–228. doi: 10.1021/ar500314j. pmid:25590654
- 47. Brown PM, Steers J, Hui SW, Yeagle PL, Silvius JR (1986) Role of head group structure in the phase behavior of amino phospholipids. 2. Lamellar and nonlamellar phases of unsaturated phosphatidylethanolamine analogues. Biochemistry 25: 4259–4267. pmid:3756138 doi: 10.1021/bi00363a013
- 48. Yeagle PL, Bennett M, Lemaitre V, Watts A (2007) Transmembrane helices of membrane proteins may flex to satisfy hydrophobic mismatch. Biochim Biophys Acta 1768: 530–537. pmid:17223071 doi: 10.1016/j.bbamem.2006.11.018
- 49. McKinney MK, Cravatt BF (2003) Evidence for distinct roles in catalysis for residues of the serine-serine-lysine catalytic triad of fatty acid amide hydrolase. J Biol Chem 278: 37393–37399. pmid:12734197 doi: 10.1074/jbc.m303922200
- 50. Kuhn B, Gerber P, Schulz-Gasch T, Stahl M (2005) Validation and use of the MM-PBSA approach for drug discovery. J Med Chem 48: 4040–4048. pmid:15943477 doi: 10.1021/jm049081q
- 51. Kuhn B, Kollman PA (2000) Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models. J Med Chem 43: 3786–3791. pmid:11020294 doi: 10.1021/jm000241h
- 52. Case DA, Darden TA, Cheatham TEI, Simmerling CL, Wang J, et al. (2012) AMBER 12 San Francisco: University of California.
- 53. Applegate KR, Glomset JA (1986) Computer-Based Modeling of the Conformation and Packing Properties of Docosahexaenoic Acid. J Lipid Res 27: 658–680. pmid:2943846
- 54. Barnett-Norris J, Guarnieri F, Hurst DP, Reggio PH (1998) Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. J Med Chem 41: 4861–4872. pmid:9822555 doi: 10.1021/jm9803471
- 55. Lynch DL, Reggio PH (2005) Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (Anandamide) in a phospholipid bilayer: Probing structure and dynamics. J Med Chem 48: 4824–4833. pmid:16033262 doi: 10.1021/jm058185d
- 56. Mileni M, Kamtekar S, Wood DC, Benson TE, Cravatt BF, et al. (2010) Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation. J Mol Biol 400: 743–754. doi: 10.1016/j.jmb.2010.05.034. pmid:20493882
- 57. Giuffrida A, Beltramo M, Piomelli D (2001) Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Ther Exper 298: 7–14.
- 58. Piomelli D, Beltramo M, Glasnapp S, Lin SY, Goutopoulos A, et al. (1999) Structural determinants for recognition and translocation by the anandamide transporter. Proc Natl Acad Sci U S A 96: 5802–5807. pmid:10318965 doi: 10.1073/pnas.96.10.5802
- 59. Labar G, Vliet FV, Wouters J, Lambert DM (2008) A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison. Amino Acids 34: 127–133. pmid:17476568 doi: 10.1007/s00726-007-0540-1
- 60. Antikainen NM, Smiley RD, Benkovic SJ, Hammes GG (2005) Conformation coupled enzyme catalysis: Single-molecule and transient kinetics investigation of dihydrofolate reductase. Biochemistry 44: 16835–16843. pmid:16363797 doi: 10.1021/bi051378i
- 61. Min W, Xie XS, Bagchi B (2009) Role of conformational dynamics in kinetics of an enzymatic cycle in a nonequilibrium steady state. J Chem Phys 131. doi: 10.1063/1.3207274
- 62. Westphal AH, Matorin A, Hink MA, Borst JW, van Berkel WJH, et al. (2006) Real-time enzyme dynamics illustrated with fluorescence spectroscopy of p-hydroxybenzoate hydroxylase. J Biol Chem 281: 11074–11081. pmid:16492664 doi: 10.1074/jbc.m600609200
- 63. Boger DL, Sato H, Lerner AE, Hedrick MP, Fecik RA, et al. (2000) Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide. Proc Natl Acad Sci U S A 97: 5044–5049. pmid:10805767 doi: 10.1073/pnas.97.10.5044
- 64. Boger DL, Sato H, Lerner AE, Austin BJ, Patterson JE, et al. (1999) Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition. Bioorg Med Chem Lett 9: 265–270. pmid:10021942 doi: 10.1016/s0960-894x(98)00734-3
- 65. Mei G, Di Venere A, Gasperi V, Nicolai E, Masuda KR, et al. (2007) Closing the gate to the active site: effect of the inhibitor methoxyarachidonyl fluorophosphonate on the conformation and membrane binding of fatty acid amide hydrolase. J Biol Chem 282: 3829–3836. pmid:17158103 doi: 10.1074/jbc.m605653200
- 66. Patricelli MP, Lashuel HA, Giang DK, Kelly JW, Cravatt BF (1998) Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Biochemistry 37: 15177–15187. pmid:9790682 doi: 10.1021/bi981733n
- 67. Ahn K, Johnson DS, Mileni M, Beidler D, Long JZ, et al. (2009) Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol 16: 411–420. doi: 10.1016/j.chembiol.2009.02.013. pmid:19389627
- 68. Mileni M, Garfunkle J, DeMartino JK, Cravatt BF, Boger DL, et al. (2009) Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by alpha-ketoheterocycle inhibitors revealed from cocrystal structures. J Am Chem Soc 131: 10497–10506. doi: 10.1021/ja902694n. pmid:19722626
- 69. Mileni M, Garfunkle J, Ezzili C, Kimball FS, Cravatt BF, et al. (2010) X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase. J Med Chem 53: 230–240. doi: 10.1021/jm9012196. pmid:19924997
- 70. Min X, Thibault ST, Porter AC, Gustin DJ, Carlson TJ, et al. (2011) Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH). Proc Natl Acad Sci U S A 108: 7379–7384. doi: 10.1073/pnas.1016167108. pmid:21502526
- 71. Kiefer JR, Pawlitz JL, Moreland KT, Stegeman RA, Hood WF, et al. (2000) Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature 405: 97–101. pmid:10811226 doi: 10.1038/35011103
- 72. Malkowski MG, Ginell SL, Smith WL, Garavito RM (2000) The productive conformation of arachidonic acid bound to prostaglandin synthase. Science 289: 1933–1937. pmid:10988074 doi: 10.1126/science.289.5486.1933
- 73. Vecchio AJ, Simmons DM, Malkowski MG (2010) Structural Basis of Fatty Acid Substrate Binding to Cyclooxygenase-2. J Biol Chem 285: 22152–22163. doi: 10.1074/jbc.M110.119867. pmid:20463020
- 74. Zhang W, Chakravarty B, Zheng F, Gu ZW, Wu HM, et al. (2011) Crystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo-gamma-linolenic acid. Proc Natl Acad Sci U S A 108: 15757–15762. doi: 10.1073/pnas.1112334108. pmid:21908709
- 75. Zhang W, Chakravarty B, Zheng F, Gu Z, Wu H, et al. (2011) Crystal structure of FAS thioesterase domain with polyunsaturated fatty acyl adduct and inhibition by dihomo-gamma-linolenic acid. Proc Natl Acad Sci U S A 108: 15757–15762. doi: 10.1073/pnas.1112334108. pmid:21908709
- 76. Pemble CWt, Johnson LC, Kridel SJ, Lowther WT (2007) Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat. Nat Struct Mol Biol 14: 704–709. pmid:17618296 doi: 10.1038/nsmb1265
- 77. Rhizomucor Miehei lipase [4TGL.pdb—Derewenda et. al. (1992) Biochemistry 31: 1532–1541]; Candida Antarctica lipase [1LBS.pdb—Uppenberg et al. (1995) Biochemistry 34: 16838–16851]; Pseudomonas cepacia lipase [2LYP.pdb—Schrag et al. (1997) Structure 5: 187–202]; Human Pancreatic lipase [1LPB.pdb—Egloff et al. (1995) Biochemistry 34: 2751–2762]; Candida rugosa lipase [1LPO.pdb—Grochulsky et al. (1994) Biochemistry 33: 3494–3500].
- 78. Pleiss J, Fischer M, Schmid RD (1998) Anatomy of lipase binding sites: the scissile fatty acid binding site. Chem Phys Lipids 93: 67–80. pmid:9720251 doi: 10.1016/s0009-3084(98)00030-9
- 79. De Vivo M (2011) Bridging quantum mechanics and structure-based drug design. Front Biosci-Landmark 16: 1619–1633. pmid:21196252 doi: 10.2741/3809